Scholarlink

Background <p>This study aims to compare the internal intercostal membrane-origin block (IIMOB) with the thoracic paravertebral block (TPVB), analyzing the postoperative analgesic efficacy and safety in patients undergoing video-assisted thoracoscopic surgery (VATS).</p> Methods <p>A total of 236 patients were enrolled. Patients undergoing uniport VATS were randomized to uniport TPVB (UP) or uniport IIMOB (UI) (<i>n</i> = 54 each), and those undergoing multiport VATS were randomized to multiport TPVB (MP) or multiport IIMOB (MI) (<i>n</i> = 54 each). Postoperatively, patients in UP and MP groups received TPVB, while those in UI and MI groups received IIMOB. Additional VATS patients were randomly divided into two groups (<i>n</i> = 10 each), methylene blue TPVB (BP) and methylene blue IIMOB (BI) groups, to assess injectate spread. The primary outcome was postoperative analgesic efficacy, quantified as the area under the curve (AUC) of Numerical Rating Scale&#xa0;(NRS) scores at rest and during coughing from 3 to 48&#xa0;h after surgery.</p> Results <p>Compared with TPVB, IIMOB was associated with&#xa0;lower postoperative NRS-AUC values at&#xa0;rest and during&#xa0;coughing (all&#xa0;<i>P</i> &lt; 0.05), reduced sufentanil consumption within 48&#xa0;h, delayed first pump use, and smaller increases in plasma levels of perioperative inflammatory and neuroendocrine stress biomarkers at 24&#xa0;h post operation. Additionally, patients received IIMOB experienced fewer incidences of back pain, hypotension, vascular injury, and block failure. There was no significant difference in the methylene blue diffusion gaps between the BI and BP groups. However, the BP group had a larger blue-dyed area in the ventral region of spinal column and higher 90-min dye color change rate compared with the BI group.</p> Conclusion <p>These findings revealed that IIMOB provided superior analgesia with fewer adverse events than TPVB after VATS.</p> Clinical trial registration <p>Chinese Clinical Trial Registry, ChiCTR2400082500. Registered on 29 March 2024, <a href="http://www.chictr.org.cn/ChiCTR2400082500">http://www.chictr.org.cn/ChiCTR2400082500</a>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Efficacy of internal intercostal membrane-origin block versus thoracic paravertebral block for postoperative analgesia after video-assisted thoracoscopic surgery: a randomized controlled trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月21日

查看全文
  • Jun-Jie Ye,
  • Qing Lin,
  • Zhen-Jun Fang,
  • Li Chen,
  • Ying Yu,
  • Lin-Fang Zhang,
  • Jin-Hua Chen,
  • Bin Zheng,
  • Shu-Chen Chen,
  • Wei-Feng Yu,
  • Jie Tian,
  • Zhong-Meng Lai

摘要

Background

This study aims to compare the internal intercostal membrane-origin block (IIMOB) with the thoracic paravertebral block (TPVB), analyzing the postoperative analgesic efficacy and safety in patients undergoing video-assisted thoracoscopic surgery (VATS).

Methods

A total of 236 patients were enrolled. Patients undergoing uniport VATS were randomized to uniport TPVB (UP) or uniport IIMOB (UI) (n = 54 each), and those undergoing multiport VATS were randomized to multiport TPVB (MP) or multiport IIMOB (MI) (n = 54 each). Postoperatively, patients in UP and MP groups received TPVB, while those in UI and MI groups received IIMOB. Additional VATS patients were randomly divided into two groups (n = 10 each), methylene blue TPVB (BP) and methylene blue IIMOB (BI) groups, to assess injectate spread. The primary outcome was postoperative analgesic efficacy, quantified as the area under the curve (AUC) of Numerical Rating Scale (NRS) scores at rest and during coughing from 3 to 48 h after surgery.

Results

Compared with TPVB, IIMOB was associated with lower postoperative NRS-AUC values at rest and during coughing (all P < 0.05), reduced sufentanil consumption within 48 h, delayed first pump use, and smaller increases in plasma levels of perioperative inflammatory and neuroendocrine stress biomarkers at 24 h post operation. Additionally, patients received IIMOB experienced fewer incidences of back pain, hypotension, vascular injury, and block failure. There was no significant difference in the methylene blue diffusion gaps between the BI and BP groups. However, the BP group had a larger blue-dyed area in the ventral region of spinal column and higher 90-min dye color change rate compared with the BI group.

Conclusion

These findings revealed that IIMOB provided superior analgesia with fewer adverse events than TPVB after VATS.

Clinical trial registration

Chinese Clinical Trial Registry, ChiCTR2400082500. Registered on 29 March 2024, http://www.chictr.org.cn/ChiCTR2400082500.